Surfactants for treatment of conditions through targeted necrosis
AssigneeImuneks Farma Ilac San. Ve Tic. A.S.
InventorMehmet Nevzat PISAK
Life of this patent
Estimating the term…
Abstract
The present invention relates to a surfactant, or a pharmaceutically acceptable salt of a surfactant or a stereoisomer of a surfactant, and a pharmaceutical composition including the surfactant, for the treatment of conditions of the cervix/anogenital region and non-melanoma skin cancers (NMSCs). The composition may comprise an anionic or amphoteric surfactant, or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the surfactant comprises: a hydrophilic moiety selected from the group consisting of a carbonate, a sulfonate, and a sulfate; and at least one pharmaceutically acceptable excipient. Methods of using the surfactant and composition are also disclosed.
Claims21
1-21. (canceled)
An anionic or amphoteric surfactant for use in the treatment of pre-cancerous conditions of the cervix/anogenital region and non-melanoma skin cancers (NMSCs).
A pharmaceutical composition for use in the treatment of pre-cancerous conditions of the cervix/anogenital region and non-melanoma skin cancers (NMSCs), the composition comprising:
- an anionic or amphoteric surfactant, or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the surfactant further comprises a hydrophilic moiety selected from the group consisting of a carbonate, a sulfonate, and/or a sulfate and at least one pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.